You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

445 Results
Guidelines and Advice
Status: In-Review
ID: GL 2-33
Jun 2022
Guidelines and Advice
Status: In-Review
ID: 15-12
Version: 2
Jan 2015
Document
New
May 2025
Document
New
May 2025
Document
New
May 2025
Document
New
May 2025
Regimen
Cancer Type:
Genitourinary, 
Prostate
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative, Palliative
Funding:
ODB - General Benefit
    relugolix
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
relugolix
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
May 2025
Guidelines and Advice
Status: In-Review
ID: 8-8
Aug 2014
Drug
Other Name(s): Orgovyx®
Quick Link(s): Drug Monograph, Patient Info Sheet
May 2025
Regimen
Cancer Type:
Sarcoma, 
Soft Tissue
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
trabectedin (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
May 2025

Pages